All
POLL: Which of These Rare Dermatologic Diseases Have You Encountered in Your Practice?
Click here to answer our poll on rare dermatologic diseases.
Rare Disease Rundown: Rare Disease News From the Past 365 Days
Today is Rare Disease Day. Here's a look back at news related to rare skin conditions over the past year.
Mindera Health and Liviniti Partner to Improve the Management of Psoriasis With Precision Medicine
As a pharmacy benefit manager, Livinti will help reduce biologic drug costs for self-funded employees.
Navigating Rare Dermatologic Diseases Using Artificial Intelligence
This Rare Disease Day, Joseph Zabinski, PhD, MEM, of OM1, discusses the role of artificial intelligence in helping to detect rare dermatologic diseases.
In Japan, Arcutis and Sato Enter Strategic Collaboration and Licensing Agreement for Topical Roflumilast
The collaboration with Sato marks a continued effort of Arcutis to collaborate with pharmaceutical companies and license topical roflumilast in Asia.
Revolutionizing GPP Recognition Through Data Collection
This Rare Disease Day, Stefan Weiss, MD, MBA, FAAD, of OM1, shares his expertise in AI’s capabilities in dermatology.
Celebrating Black History Month in Dermatology
Review Dermatology Times’ February content uplifting Black voices.
Early Intervention: Shutting Down AD’s Atopic March
Timely systemic treatment of atopic dermatitis—before visible lesions appear—may help halt the atopic march into allergies and asthma.
Delivering on Diversity in Clinical Trials: Getting Started
Susan Taylor, MD, believes in training more investigators that serve diverse populations to enhance clinical trials. Here are a few resources to get started in clinical trials.
B-Raf Inhibitor Receives FDA Orphan Drug Designation for Treatment of EGFRI-Induced Acneiform Rash
Most patients undergoing EGFRI treatment for cancer will develop acneiform lesions, yet no drug is currently approved by the FDA for their prevention or treatment.
Interview Intersection: Expert Interviews From February 2024
Dermatology Times is recapping our top expert interviews from the month of February.
Adewole (Ade) Adamson, MD, MPP: Systemic Racism, Patient Access, and Advancing Health Equity
Adamson recently shared with Dermatology Times about the significance of Vaseline's Mended Murals initiative and the role of dermatologists in improving patient access.
Surveying Our Readers: What Are Your Thoughts on the New AAD Acne Guidelines?
We want to hear from you. Please take the time to respond to our survey.
New Topical Agent for Alopecia to Enter Phase 2 Trials
Data on the phase 1 trial of the small molecule agent for treatment of androgenetic alopecia and other forms of hair loss will be presented at the AAD meeting in March.
Severity of Psoriatic Disease Significantly Associated With Risk of Inflammatory Bowel Disease
A recent study identified an association between psoriasis severity and IBD, Crohn disease, and ulcerative colitis.
More Research Needed Regarding Dietary Considerations for Patients With Hidradenitis Suppurativa, Review Finds
Findings regarding an association between HS severity and dietary elements such as vitamin D, B12 supplementation, and more, are inconclusive.
Integrated Data From BRAVE-AA1 and BRAVE-AA2 Trials Supports Efficacy of Baricitinib Over 104 Weeks in Alopecia Areata
Long-term treatment showed increased efficacy in patients who responded partially in week 52, indicating the importance of extended therapy for maximizing benefits in certain individuals.
Are Aerobics or Weights Better for Aging Skin?
Resistance training rejuvenates aging skin differently than aerobics training, according to a new study.
Expert Insights Into the Relationship Between the Hippo Pathway and Extensive Fibrosis in HS
Researchers from the University of Michigan and Almirall found that the profibrotic fibroblast response in HS can be modulated through inhibition of the Hippo pathway.
Hair and Skin Publications From Sub-Saharan Africa Are Steadily Increasing, Researchers Report
Researchers involved in the review said this increase may help lead to more patient education and more tailored products for patients from this region.
Rilzabrutinib Rapidly Reduces Itch Severity in Adults with Chronic Spontaneous Urticaria
Late-breaking phase 2 data was presented at the 2024 American Academy of Allergy, Asthma and Immunology Annual Meeting.
Platelet-Rich Plasma for Hair Restoration and Skin Rejuvenation: Benefits Recognized, Consensus Needed
Platelet-rich plasma (PRP) holds great promise for regenerative hair and skin applications, but trials, standards, and protocols are needed, one review has found.
Can Costs and Benefits of Psoriasis Treatments Be Better Aligned?
Biologics to treat psoriasis can cost between $1664 and $79,277 a year in the United States, one study found, and these prices are not commensurate with clinical benefits.
ICYMI: FDA Approves Third Interchangeable Humira Biosimilar Simlandi
Simlandi (adalimumab-ryvk) joins Pfizer’s Abrilada (adalimumab-afzb) and Boehringer Ingelheim’s Cyltezo (adalimumab-adbm) as an interchangeable Humira biosimilar.
Despite Maternal Mental Health and Child Atopic Disease Association, This Link Is Not Attributable to Child Mental Health Disorders
Maternal mental health conditions are associated with the majority of atopic diseases, according to a study.
Derm In The News: February 18-24
Keep up with the latest headlines in dermatology from the past week, including the rise of dermatologists offering skin health services for people of color, isotretinoin and its ocular impact, and more.
The Weekly Roundup: February 18-23
ICYMI, this week we had news about Masterclasses in Dermatology insights, Alaskapox and skin lesions, improving skin of color representation in dermatology, and more.
La Roche-Posay Unveils New Molecule in Mela B3 Serum to Target Discoloration
Data on pigmentary disorders worldwide and clinical study results were presented at the IMCAS World Congress 2024 meeting.
Improving Representation of Skin of Color in Dermatology
Miranda Uzoma Ewelukwa, MD, FAAD, reviews how skin of color representation has evolved in dermatology, however, more advocacy is still needed.
Atopic Dermatitis Itch May Be Caused by Microbes, Not Inflammation
Researchers have found Staphylococcus aureus may trigger itchiness in atopic dermatitis, opening the door to new treatment approaches in the future.